Raina, R., Jothi, S., Haffner, D., Somers, M., Filler, G., Vasistha, P., Chakraborty, R., Shapiro, R., Randhawa, P. S., Parekh, R., Licht, C., Bunchman, T., Sethi, S., Mangat, G., Zaritsky, J., Schaefer, F., Warady, B., Bartosh, S., McCulloch, M., … Radhakrishnan, J. (2024). Post-transplant recurrence of focal segmental glomerular sclerosis: consensus statements. Kidney International, 105(3), 450–463. https://doi.org/10.1016/j.kint.2023.10.017

Duret, L. C., Hamidouche, T., Steers, N. J., Pons, C., Soubeiran, N., Buret, D., Gilson, E., Gharavi, A. G., D’Agati, V. D., & Shkreli, M. (2024). Targeting WIP1 phosphatase promotes partial remission in experimental collapsing glomerulopathy. Kidney International, 105(5), 980–996. https://doi.org/10.1016/j.kint.2024.02.009

Marchel, D., Trachtman, H., Larkina, M., Helmuth, M., Lai Yee, J. Y., Fermin, D., Bomback, A. S., Canetta, P. A., Gipson, D. S., Mottl, A. K., Parekh, R. S., Saha, M. K., Sampson, M. G., Lafayette, R. A., & Mariani, L. H. (2023). The Significance of Hematuria in Podocytopathies. Clinical Journal of the American Society of Nephrology, 19(1), 56–66. https://doi.org/10.2215/cjn.0000000000000309

Gupta, Y., Friedman, D. J., McNulty, M. T., Khan, A., Lane, B., Wang, C., Ke, J., Jin, G., Wooden, B., Knob, A. L., Lim, T. Y., Appel, G. B., Huggins, K., Liu, L., Mitrotti, A., Stangl, M. C., Bomback, A., Westland, R., Bodria, M., … Sanna-Cherchi, S. (2023). Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease. Nature Communications, 14(1). https://doi.org/10.1038/s41467-023-43020-9

Rheault, M. N., Alpers, C. E., Barratt, J., Bieler, S., Canetta, P., Chae, D.-W., Coppock, G., Diva, U., Gesualdo, L., Heerspink, H. J. L., Inrig, J. K., Kirsztajn, G. M., Kohan, D., Komers, R., Kooienga, L. A., Lieberman, K., Mercer, A., Noronha, I. L., Perkovic, V., … Trachtman, H. (2023). Sparsentan versus Irbesartan in Focal Segmental Glomerulosclerosis. New England Journal of Medicine, 389(26), 2436–2445. https://doi.org/10.1056/nejmoa2308550

Nasr, S. H., Kudose, S., Javaugue, V., Harel, S., Said, S. M., Pascal, V., Stokes, M. B., Vrana, J. A., Dasari, S., Theis, J. D., Osuchukwu, G. A., Sathick, I. J., Das, A., Kashkouli, A., Suchin, E. J., Liss, Y., Suldan, Z., Verine, J., Arnulf, B., … D’Agati, V. D. (2023). Pathological characteristics of light chain crystalline podocytopathy. Kidney International, 103(3), 616–626. https://doi.org/10.1016/j.kint.2022.11.026

Mariani, L. H., Eddy, S., AlAkwaa, F. M., McCown, P. J., Harder, J. L., Nair, V., Eichinger, F., Martini, S., Ademola, A. D., Boima, V., Reich, H. N., El Saghir, J., Godfrey, B., Ju, W., Tanner, E. C., Vega-Warner, V., Wys, N. L., Adler, S. G., Appel, G. B., … Kretzler, M. (2023). Precision nephrology identified tumor necrosis factor activation variability in minimal change disease and focal segmental glomerulosclerosis. Kidney International, 103(3), 565–579. https://doi.org/10.1016/j.kint.2022.10.023

Kallash, M., Wang, Y., Smith, A., Trachtman, H., Gbadegesin, R., Nester, C., Canetta, P., Wang, C., Hunley, T. E., Sperati, C. J., Selewski, D., Ayoub, I., Srivastava, T., Mottl, A. K., Kopp, J., Gillespie, B., Robinson, B., Chen, D., … Steinke, J. (2023). Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes. Clinical Journal of the American Society of Nephrology, 18(3), 344–355. https://doi.org/10.2215/cjn.0000000000000069

Batal, I., Khairallah, P., Weins, A., Andeen, N. K., & Stokes, M. B. (2023). The role of HLA antigens in recurrent primary focal segmental glomerulosclerosis. Frontiers in Immunology, 14. https://doi.org/10.3389/fimmu.2023.1124249

Valdez Imbert, R., Hti Lar Seng, N. S., Stokes, M. B., & Jim, B. (2022). Obesity-related glomerulopathy in the presence of APOL1 risk alleles. BMJ Case Reports, 15(8), e249624. https://doi.org/10.1136/bcr-2022-249624